EUVIMEDEUVIMED entdecken
Crossref

Predictors of graft failure after first detection of de novo donor-specific HLA antibodies in kidney transplant recipients

Covadonga López Del Moral iD, Kaiyin Wu, Marcel Naik iD, Bilgin Osmanodja, Aylin Akifova, Nils Lachmann, Diana Stauch, Sabine Hergovits, Mira Choi, Friederike Bachmann, Fabian Halleck, Eva Schrezenmeier und 2 weitere

Nephrology Dialysis Transplantation · 2023

DOI: 10.1093/ndt/gfad149 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nephrology Dialysis Transplantation, 2023. Verfasst von Covadonga López Del Moral und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology and Medical Intensive Care, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-…. Hauptthemen laut MEDLINE: Kidney Transplantation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Valdecilla Biomedical Research Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

De novo donor-specific antibodies (dnDSAs) may cause antibody-mediated rejection and graft dysfunction. Little is known about the clinical course after first detection of dnDSAs during screening in asymptomatic patients. We aimed to assess the value of estimated glomerular filtration rate (eGFR) and proteinuria to predict graft failure in patients with dnDSAs and their potential utility as surrogate endpoints.

Methods

All 400 kidney transplant recipients with dnDSAs at our centre (1 March 2000–31 May 2021) were included in this retrospective study. The dates of graft loss, rejection, doubling of creatinine, ≥30% eGFR decline, proteinuria ≥500 mg/g and ≥1000 mg/g were registered from the first dnDSA appearance.

Results

During 8.3 years of follow-up, graft failure occurred in 33.3% of patients. Baseline eGFR and proteinuria correlated with 5-year graft loss (area under the receiver operating characteristics curve 0.75 and 0.80, P < .001). Creatinine doubled after a median of 2.8 years [interquartile range (IQR) 1.5–5.0] from dnDSA and the time from doubling creatinine to graft failure was 1.0 year (IQR 0.4–2.9). Analysing eGFR reduction ≥30% as a surrogate endpoint (148/400), the time from dnDSA to this event was 2.0 years (IQR 0.6–4.2), with a positive predictive value (PPV) of 45.9% to predict graft loss, which occurred after 2.0 years (IQR 0.8–3.2). The median time from proteinuria ≥500 mg/g and ≥1000 mg/g to graft failure was identical, 1.8 years, with a PPV of 43.8% and 49.0%, respectively. Composite endpoints did not improve PPV. Multivariable analysis showed that rejection was the most important independent risk factor for all renal endpoints and graft loss.

Conclusions

Renal function, proteinuria and rejection are strongly associated with graft failure in patients with dnDSA and may serve as surrogate endpoints.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationHumansRetrospective StudiesIsoantibodiesCreatinineGraft RejectionGraft SurvivalBiomarkersProteinuriaTissue DonorsHLA AntigensTransplant Recipients

Stichwörter der Autor:innen

GFRacute rejectionbiomarkerskidney transplantationproteinuria

Substanzen

IsoantibodiesCreatinineBiomarkersHLA Antigens

Autor:innen und Institutionen

  • Department of Nephrology and Medical Intensive Care, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Department of Nephrology, Marqués de Valdecilla University Hospital-IDIVAL, Santander, Spain.
  • Department of Pathology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Institute for Transfusion Medicine, HLA-Laboratory, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Berlin Institute of Health Charité - Universitätsmedizin Berlin, BIH Academy, Berlin, Germany.

ORCID-Profile: Covadonga López Del Moral, Marcel Naik, Klemens Budde

Förderung

  • Valdecilla Biomedical Research Institute

Zitieren

APA

López Del Moral, C., Wu, K., Naik, M., Osmanodja, B., Akifova, A., Lachmann, N., Stauch, D., Hergovits, S., Choi, M., Bachmann, F., Halleck, F., Schrezenmeier, E., Schmidt, D., & Budde, K. (2023). Predictors of graft failure after first detection of de novo donor-specific HLA antibodies in kidney transplant recipients. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfad149

Vancouver

López Del Moral C, Wu K, Naik M, Osmanodja B, Akifova A, Lachmann N, et al. Predictors of graft failure after first detection of de novo donor-specific HLA antibodies in kidney transplant recipients. Nephrology Dialysis Transplantation. 2023. doi:10.1093/ndt/gfad149

BibTeX
@article{LpezDelMoral2023,
  author = {López Del Moral, Covadonga and Wu, Kaiyin and Naik, Marcel and Osmanodja, Bilgin and Akifova, Aylin and Lachmann, Nils and Stauch, Diana and Hergovits, Sabine and Choi, Mira and Bachmann, Friederike and Halleck, Fabian and Schrezenmeier, Eva and Schmidt, Danilo and Budde, Klemens},
  title = {Predictors of graft failure after first detection of de novo donor-specific HLA antibodies in kidney transplant recipients},
  journal = {Nephrology Dialysis Transplantation},
  year = {2023},
  doi = {10.1093/ndt/gfad149}
}
Kostenlos starten →